Selected Publications


Autry A, Vaziri S, Gordon JW, Chen HY, Kim Y, Dang D, LaFontaine M, Noeske R, Bok R, Villanueva-Meyer JE, Clarke JL, Oberheim Bush NA, Chang SM, Xu D, Lupo JM, Larson PEZ, Vigneron DB, and Li YAdvanced Hyperpolarized 13C Metabolic Imaging Protocol for Patients with Gliomas: A Comprehensive Multimodal MRI Approach. Cancers. 2024. 16(2). 354. 


Jakary A, Lupo JM, Mackin S, Yin A, Murray D, Yang T, Mukherjee P, Larson P, Xu D, Eisendrath S, Luks T, and Li Y. Evaluation of Major Depressive Disorder using 7 Tesla Phase Sensitive Neuroimaging Before and After Mindfulness-Based Cognitive Therapy. Journal of Affective Disorders. 2023. 335:383-391. PMID: 37192691. 

Autry A, Vaziri S, LaFontaine M, Gordon JW, Chen H-Y, Kim Y, Villanueva-Meyer JE, Molinaro A, Clarke JL, Oberheim-Bush NA, Xu D, Lupo JM, Larson PEZ, Vigneron DB, Chang SM, and Li Y. Multi-parametric hyperpolarized 13C/1H imaging reveals Warburg-related metabolic dysfunction and associated regional heterogeneity in high-grade human gliomas. NeuroImage: Clinical. 2023: 39:103501. PMID: 37611371. PMCID: PMC10470324.

Liu H, Autry AW, Larson PEZ, Xu D, and Li YAtlas-based adaptive Hadamard-encoded Magnetic Resonance Spectroscopic Imaging at 3T. Tomography. 2023. 9; 1592-1602. PMID: 37736980. PMCID: PMC10514830. 

Vaziri S, Liu H, Xie E, Ratiney H, Sdika M, Lupo JM, Xu D, and Li Y. Evaluation of Deep learning models for quality control of MR spectra. Frontiers in Neuroscience - Brain Imaging Methods. 2023; 17:1219343. PMID: 37706154. PMCID: PMC10495580. 

Chung BT, Kim Y, Gordon JW, Chen HY, Autry AW, Lee P, Hu J, Tan CT, Suszczynski C, Chang S, Villaneuva-Meyer J, Bok RA, Larson PEZ, Xu D, Li Y, and Vigneron DB. Hyperpolarized [2-13C]Pyruvate MR Molecular Imaging with Whole Brain Coverage. NeuroImage. 2023; 280:120350. PMID: 37634883.


Autry AW, Lafontaine M, Jalbert L, Phillips E, Phillips JJ, Villanueva-Meyer J, Berger MS, Chang SM, and Li Y. Spectroscopic imaging of D-2-hydroxyglutarte and other metabolites in pre-surgical patients with IDH-mutant lower-grade gliomas. J Neurooncol. 2022. 159(1):43-52. PMID: 35672531. PMCID: PMC9325821.

Vaziri S, Autry AW, Lafontaine M, Kim Y, Gordon JW, Chen HY, Hu JY, Lupo JM, Chang SM, Clarke JL, Villanueva-Meyer JE, Oberheim Bush NA, Xu D, Larson PEZ, Vigneron DB, and Li Y. Assessment of High-order Singular Value Decomposition Denoising Methods on Dynamic Hyperpolarized [1-13C]pyruvate MRI Data from Patients with Glioma. NeuroImage Clinical. 2022; 36:103155. PMCID: PMC9421383.


Autry A, Park I, Kline C, Chen HY, Gordon JW, Raber S, Hoffman C, Kim Y, Okamoto K, Vigneron DB, Lupo JM, Prados M, Li Y, Xu D, and Mueller S. Pilot study of hyperpolarized 13C metabolic imaging in pediatric patients with DIPG and other CNS cancers. AJNR. 2021; 42(1):178-184. PMID: 33272950. PMCID: PMC7814790.

Krysko KM, Bischof A, Nourbakhsh B, Henry RG, Revirajan N, Manguinao M, Nguyen K, Akula A, Li Y*, Waubant E*. A pilot study of oxidative pathways in MS fatigue: Randomized trial of N-acetyl cysteine. Ann Clin Trans Neurol. 2021;8(4):811-824 (*These authors contributed equally). PMID: 33675156. PMCID: PMC8045913.

Li Y, Vigneron DB, Xu D. Current human brain applications and challenges of dynamic hyperpolarized carbon‐13 labeled pyruvate MR metabolic imaging. Eur J Nucl Med Mol Imaging. 2021. 48(13):4225-4235. PMID: 34432118. PMCID: PMC8566394


Autry A, Gordon JW, Chen H-Y, LaFontaine M, Bok R, VanCriekinge M, Slater JB, Carvajal, Villanueva-Meyer JE, Chang SM, Clarke JL, Lupo JM, Xu D, Larson PEZ, Vigneron DB, and Li Y. Characterization of serial hyperpolarized 13C metabolic imaging in patients with glioma. NeuroImage clinical. 2020. 27:102323. PMID: 32623139. PMCID: PMC7334458.

Crane JC, Gordon J, Chen HY, Autry AW, Li Y, Olson MP, Kurhanewicz J, Vigneron DB, Larson PEZ, and Xu D. Hyperpolarized 13C MRI data acquisition and analysis in prostate and brain at University of California, San Francisco. NMR in Biomed. 2021; 34(5): e4280. PMID: 32189442. PMCID: PMC7501204.2019